|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.93 CNY | -0.93% |
|
-3.45% | -9.59% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.93% | -3.45% | -14.90% | -19.01% | -9.59% | -8.40% | -42.47% | -61.25% | - | 2.68B | |
| +1.01% | -1.30% | -17.03% | -20.21% | -31.71% | -3.81% | -22.49% | -63.02% | - | 15.53B | |
| +0.56% | -1.10% | -18.78% | -27.77% | -28.91% | -22.46% | -27.18% | -81.74% | -38.21% | 7.41B | |
| +0.35% | +0.99% | -1.10% | -5.11% | -15.45% | -19.83% | -12.48% | +34.36% | +132.79% | 5.63B | |
| +1.02% | -5.87% | -14.22% | -14.37% | -8.38% | -25.83% | -32.53% | -47.83% | +91.22% | 3.56B | |
| -0.67% | -2.03% | -6.36% | -1.48% | +1.53% | -19.49% | -44.57% | - | - | 3.34B | |
| -0.08% | +0.21% | -10.39% | -23.50% | -30.18% | -38.31% | -5.13% | -10.65% | +106.14% | 3.33B | |
| -0.63% | -2.20% | -4.48% | -10.98% | -14.93% | -20.30% | -4.29% | +39.58% | +116.63% | 2.57B | |
| -0.78% | +4.49% | +8.70% | +19.27% | +34.53% | +93.50% | - | - | - | 2.56B | |
| +0.68% | -6.43% | -8.71% | -7.47% | -6.51% | +0.77% | +41.52% | +6.16% | - | 1.7B | |
| -1.04% | +1.60% | +7.61% | +7.30% | +34.07% | +70.60% | +81.32% | +210.67% | +331.15% | 1.16B | |
| -0.03% | -.--% | -.--% | -.--% | -.--% | -.--% | -.--% | -9.19% | -5.55% | 1.14B | |
| -4.13% | +10.72% | -0.58% | +9.32% | -25.78% | -50.97% | -49.31% | -68.50% | - | 1.12B | |
| -0.03% | -4.08% | -0.02% | +3.39% | +6.37% | -6.23% | +6.57% | - | - | 1.08B | |
| -0.76% | -3.25% | -5.39% | -2.24% | -5.69% | -40.20% | -51.33% | - | - | 1.07B | |
| +1.52% | -1.90% | -10.49% | -12.29% | -11.74% | -33.35% | -59.07% | -70.04% | -51.60% | 962M | |
| -0.91% | -8.18% | -23.87% | -14.68% | -12.34% | +30.89% | -11.34% | - | - | 961M | |
| +1.46% | +4.35% | -1.54% | +30.55% | -16.83% | -19.20% | - | - | - | 845M | |
| -0.57% | +1.59% | +7.17% | -4.87% | -4.75% | +7.91% | -23.60% | - | - | 841M | |
| +3.65% | +1.19% | -3.27% | -16.13% | -31.35% | +0.44% | +56.19% | +92.10% | - | 648M | |
| Average | -0.02% | -1.29% | -5.88% | -5.51% | -8.88% | -5.21% | -11.12% | -2.26% | +85.32% | 2.91B | |
| Weighted average by Cap. | +0.26% | -1.20% | -10.12% | -12.38% | -16.44% | -8.47% | -18.58% | -31.60% | +68.74% |
- Stock Market
- Equities
- 603233 Stock
- Sector DaShenLin Pharmaceutical Group Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition